Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study

BACKGROUND/PURPOSE: MVC-COV1901 is a protein vaccine based on the same SARS-CoV-2 strain used in mRNA vaccine mRNA-1273. Data are lacking on immunogenicity and safety of MVC-COV1901 as heterologous boost for people already received one dose of mRNA-1273. METHODS: This is a randomized, double-blind t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Szu-Ting, Huang, Yu-Shan, Liu, Wang-Da, Pan, Sung-Ching, Sun, Hsin-Yun, Lien, Chia-En, Chen, Charles, Hsieh, Szu-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264237/
https://www.ncbi.nlm.nih.gov/pubmed/37321955
http://dx.doi.org/10.1016/j.jfma.2023.05.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264237/
https://www.ncbi.nlm.nih.gov/pubmed/37321955
http://dx.doi.org/10.1016/j.jfma.2023.05.030

Ejemplares similares